Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.080
0.00 (0.00%)
Jul 27, 2026, 3:43 PM CET
Arterra Bioscience Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21 | 20 | 13 | 11 | 14 | 19 | |
Market Cap Growth | 12.41% | 54.08% | 18.07% | -23.15% | -25.52% | 3.52% |
Enterprise Value | 19.43 | 19.29 | 10.42 | 8.14 | 8.88 | 15.11 |
Last Close Price | 3.08 | 3.02 | 1.96 | 1.66 | 2.16 | 2.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.22 | 10.02 | 9.76 | 10.27 | 10.17 | 17.39 |
PS Ratio | 4.36 | 3.29 | 2.48 | 2.23 | 2.71 | 4.19 |
PB Ratio | 1.63 | 1.75 | 1.14 | 1.03 | 1.37 | 2.04 |
P/TBV Ratio | 1.78 | 1.75 | 1.14 | 1.03 | 1.40 | 2.14 |
P/FCF Ratio | 13.33 | 13.07 | 30.81 | 11.51 | 11.05 | 22.56 |
P/OCF Ratio | 10.29 | 10.09 | 12.26 | 10.77 | 10.31 | 13.82 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.13 | 3.15 | 1.98 | 1.64 | 1.67 | 3.28 |
EV/EBITDA Ratio | 14.60 | 8.68 | 6.09 | 5.11 | 4.16 | 8.71 |
EV/EBIT Ratio | 18.68 | 9.98 | 7.59 | 7.68 | 5.55 | 12.11 |
EV/FCF Ratio | 12.62 | 12.53 | 24.60 | 8.48 | 6.83 | 17.65 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.06 | 0.03 | 0.05 |
Debt / EBITDA Ratio | 0.39 | 0.23 | 0.42 | 0.49 | 0.23 | 0.35 |
Debt / FCF Ratio | 0.34 | 0.34 | 1.68 | 0.80 | 0.38 | 0.72 |
Net Debt / Equity Ratio | -0.07 | -0.07 | -0.23 | -0.27 | -0.53 | -0.44 |
Net Debt / EBITDA Ratio | -0.62 | -0.37 | -1.54 | -1.83 | -2.58 | -2.42 |
Net Debt / FCF Ratio | -0.53 | -0.53 | -6.21 | -3.03 | -4.23 | -4.91 |
Asset Turnover | 0.44 | 0.44 | 0.41 | 0.39 | 0.44 | 0.42 |
Inventory Turnover | 1.32 | 1.32 | 1.34 | 1.37 | 2.00 | 2.47 |
Quick Ratio | 1.03 | 1.03 | 2.28 | 4.63 | 5.19 | 6.51 |
Current Ratio | 5.27 | 5.27 | 5.66 | 5.59 | 8.49 | 6.91 |
Return on Equity (ROE) | 17.49% | 17.49% | 12.06% | 10.14% | 14.18% | 12.58% |
Return on Assets (ROA) | 7.46% | 13.86% | 8.31% | 6.97% | 10.43% | 9.93% |
Return on Invested Capital (ROIC) | 9.77% | 19.92% | 12.97% | 13.67% | 24.60% | 22.37% |
Return on Capital Employed (ROCE) | 8.25% | 15.32% | 11.90% | 9.39% | 14.71% | 12.71% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.78% | 9.98% | 10.24% | 9.74% | 9.83% | 5.75% |
FCF Yield | 7.50% | 7.65% | 3.25% | 8.68% | 9.05% | 4.43% |
Dividend Yield | 4.28% | 4.21% | 5.10% | 6.02% | 0.00% | 0.00% |
Payout Ratio | 42.20% | 42.20% | 49.81% | 61.87% | 0.00% | 0.00% |
Buyback Yield / Dilution | - | 0.00% | 0.00% | 0.00% | 0.00% | -1.74% |
Total Shareholder Return | 4.28% | 4.21% | 5.10% | 6.02% | 0.00% | -1.74% |